ArticleCurrent therapeutic research, clinical and experimental2020

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Hyaluronidase PH20 Administered Intravenously in Healthy Volunteers.

Marie A Printz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.